Compare Stocks: HCAT, CTEV, NRC, and EVH

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CTEV Claritev	$22.41 -3.4%	$32.04	$11.50 ▼ $73.68	$393.18M	0.88	136,027 shs	137,334 shs
EVH Evolent Health	$3.65 +1.0%	$4.12	$2.10 ▼ $8.98	$408.14M	0.84	2.22 million shs	2.14 million shs
HCAT Health Catalyst	$1.77 +1.7%	$1.83	$0.96 ▼ $3.62	$130.95M	1.53	447,068 shs	532,639 shs
NRC National Research	$20.06 +2.5%	$21.03	$11.01 ▼ $23.68	$445.15M	0.35	122,008 shs	83,318 shs

(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CTEV Claritev	-3.20%	-28.95%	-42.09%	-34.76%	-56.44%
EVH Evolent Health	+1.56%	-1.49%	-20.93%	-32.19%	-59.32%
HCAT Health Catalyst	+1.72%	-2.21%	+11.32%	-11.06%	-36.79%
NRC National Research	+2.50%	-5.69%	-8.19%	-7.00%	+50.83%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CTEV Claritev	$22.41 -3.4%	$32.04	$11.50 ▼ $73.68	$393.18M	0.88	136,027 shs	137,334 shs
EVH Evolent Health	$3.65 +1.0%	$4.12	$2.10 ▼ $8.98	$408.14M	0.84	2.22 million shs	2.14 million shs
HCAT Health Catalyst	$1.77 +1.7%	$1.83	$0.96 ▼ $3.62	$130.95M	1.53	447,068 shs	532,639 shs
NRC National Research	$20.06 +2.5%	$21.03	$11.01 ▼ $23.68	$445.15M	0.35	122,008 shs	83,318 shs

(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CTEV Claritev	-3.20%	-28.95%	-42.09%	-34.76%	-56.44%
EVH Evolent Health	+1.56%	-1.49%	-20.93%	-32.19%	-59.32%
HCAT Health Catalyst	+1.72%	-2.21%	+11.32%	-11.06%	-36.79%
NRC National Research	+2.50%	-5.69%	-8.19%	-7.00%	+50.83%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CTEV Claritev	2.56	Moderate Buy	$44.83	100.06% Upside
EVH Evolent Health	2.63	Moderate Buy	$5.96	63.63% Upside
HCAT Health Catalyst	2.18	Hold	$2.45	38.42% Upside
NRC National Research	2.50	Moderate Buy	$26.00	29.61% Upside

Current Analyst Ratings Breakdown

Latest HCAT, CTEV, NRC, and EVH Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/21/2026	CTEV Claritev	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
9/14/2026	EVH Evolent Health	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
9/1/2026	EVH Evolent Health	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/21/2026	NRC National Research	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D+) ➝ Hold (C-)
8/20/2026	HCAT Health Catalyst	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$3.00 ➝ $1.80
8/20/2026	CTEV Claritev	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight	$28.00 ➝ $40.00
8/18/2026	EVH Evolent Health	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/18/2026	EVH Evolent Health	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$5.00 ➝ $6.00
8/17/2026	EVH Evolent Health	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$5.00 ➝ $6.00
8/13/2026	CTEV Claritev	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
8/13/2026	HCAT Health Catalyst	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Equal Weight	$1.75 ➝ $1.50

(Data available from 9/29/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CTEV Claritev	$965.41M	0.39	$14.94 per share	1.50	($10.10) per share	-2.22
EVH Evolent Health	$1.88B	0.22	$4.73 per share	0.77	$3.53 per share	1.03
HCAT Health Catalyst	$311.14M	0.43	$2.16 per share	0.82	$3.47 per share	0.51
NRC National Research	$137.39M	3.32	$1.29 per share	15.56	$0.62 per share	32.35

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CTEV Claritev	-$284.28M	-$17.01	N/A	N/A	N/A	-28.46%	N/A	-5.76%	N/A
EVH Evolent Health	-$534.51M	-$4.57	N/A	N/A	N/A	-24.08%	-4.27%	-1.06%	11/5/2026 (Estimated)
HCAT Health Catalyst	-$177.97M	-$3.68	N/A	N/A	N/A	-90.61%	-1.83%	-0.80%	11/9/2026 (Estimated)
NRC National Research	$11.60M	$0.25	80.24	N/A	N/A	4.18%	164.26%	14.67%	10/26/2026 (Estimated)

Latest HCAT, CTEV, NRC, and EVH Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
10/26/2026	Q3 2026	NRC National Research	$0.21	N/A	N/A	N/A	$35.80 million	N/A
8/7/2026	Q2 2026	CTEV Claritev	-$4.10	$1.41	+$5.51	-$3.49	N/A	$257.48 million
8/6/2026	Q2 2026	EVH Evolent Health	-$0.0104	$0.02	+$0.0304	-$0.25	$597.70 million	$484.50 million
8/6/2026	Q2 2026	HCAT Health Catalyst	$0.0299	$0.04	+$0.0101	-$0.55	$69.09 million	$70.49 million
7/28/2026	Q2 2026	NRC National Research	-$0.15	$0.31	+$0.46	-$0.15	$34.90 million	$35.39 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CTEV Claritev	N/A	N/A	N/A	N/A	N/A
EVH Evolent Health	N/A	N/A	N/A	N/A	N/A
HCAT Health Catalyst	N/A	N/A	N/A	N/A	N/A
NRC National Research	$0.64	3.19%	+19.88%	256.00%	N/A

Latest HCAT, CTEV, NRC, and EVH Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/15/2026	NRC National Research	quarterly	$0.16	3.27%	9/25/2026	9/25/2026	10/9/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CTEV Claritev	N/A	1.00	1.00
EVH Evolent Health	2.52	1.24	1.24
HCAT Health Catalyst	1.51	2.70	2.70
NRC National Research	13.13	0.65	0.65

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CTEV Claritev	87.15%
EVH Evolent Health	N/A
HCAT Health Catalyst	85.00%
NRC National Research	47.26%

Insider Ownership

Company	Insider Ownership
CTEV Claritev	7.40%
EVH Evolent Health	1.48%
HCAT Health Catalyst	19.40%
NRC National Research	9.20%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CTEV Claritev	3,000	16.95 million	15.69 million	Optionable
EVH Evolent Health	4,200	113.06 million	111.39 million	Optionable
HCAT Health Catalyst	1,200	75.26 million	60.66 million	Optionable
NRC National Research	357	22.75 million	20.65 million	Optionable

HCAT, CTEV, NRC, and EVH Headlines

Recent News About These Companies

NRC Health Trades at a Discount: Should You Buy, Sell or Hold?

September 28 at 2:35 PM | zacks.com

National Research Corporation (NASDAQ:NRC) to Issue Quarterly Dividend of $0.16

September 23, 2026 | marketbeat.com

National Research (NASDAQ:NRC) Share Price Crosses Above Two Hundred Day Moving Average - What's Next?

September 17, 2026 | marketbeat.com

New Momentum in the Nuclear Fuel Chain

September 14, 2026 | etftrends.comE

National Research (NASDAQ:NRC) Shares Pass Above 200 Day Moving Average - Should You Sell?

September 9, 2026 | marketbeat.com

Mercy Earns National Honor for Excellence in Patient Experience

September 1, 2026 | prnewswire.com

National Research (NASDAQ:NRC) Stock Passes Above 200 Day Moving Average - Time to Sell?

September 1, 2026 | marketbeat.com

Report Shows National Academies Spending Drop as Trump Threatens Funding

August 19, 2026 | aip.orgA

Record Backlog Powers NRC Health’s (NRC) Upward Potential

August 10, 2026 | insidermonkey.com

NRC Down 8% Despite Q2 Earnings Rising Y/Y on TRCV Growth

August 3, 2026 | zacks.com

National Research: Q2 Earnings Snapshot

July 30, 2026 | finance.yahoo.com

National Research (NASDAQ:NRC) Draws Fresh Market Focus

July 30, 2026 | kalkinemedia.comK

NRC Health (NRC) Q2 2026 Earnings Call Transcript

July 29, 2026 | seekingalpha.com

NRC Health Announces Second Quarter 2026 Results

July 28, 2026 | businesswire.com

Nations Royalty Reports Fiscal 2026 Year-End Results and Provides Portfolio Update

July 28, 2026 | newsfilecorp.comN

MMF and NRC Agree to the Transfer of Property at 435-445 Ellice Avenue, Winnipeg

July 10, 2026 | ca.finance.yahoo.com

National Research Shareholders Approve Governance Reforms and Directors

June 29, 2026 | tipranks.com

AtkinsRéalis submits Notice of Intent to U.S. Nuclear Regulatory Commission for CANDU® reactor licensing

June 24, 2026 | prnewswire.com

RZOLV Technologies Completes NRC IRAP-Supported R&D Project for Non-Cyanide Gold Extraction Technology

June 23, 2026 | finance.yahoo.com

Georgia's Plant Hatch receives 20-year license renewal from the Nuclear Regulatory Commission

June 15, 2026 | prnewswire.com

[SMM Aluminum Flash News] AnorTech and NRC Partner to Develop Alumina-Based CO₂ Capture Materials

June 10, 2026 | news.metal.comN

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

HCAT, CTEV, NRC, and EVH Company Descriptions

Claritev NYSE:CTEV

$22.41 -0.79 (-3.41%)

As of 09/28/2026 03:58 PM Eastern

MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. MultiPlan Corporation was founded in 1980 and is headquartered in New York, New York.

Evolent Health NYSE:EVH

$3.64 +0.04 (+0.97%)

Closing price 09/28/2026 03:58 PM Eastern

Extended Trading

$3.66 +0.01 (+0.27%)

As of 09/28/2026 07:30 PM Eastern

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

Health Catalyst NASDAQ:HCAT

$1.77 +0.03 (+1.72%)

Closing price 09/28/2026 04:00 PM Eastern

Extended Trading

$1.77 0.00 (0.00%)

As of 09/28/2026 07:30 PM Eastern

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

National Research NASDAQ:NRC

$20.06 +0.49 (+2.50%)

Closing price 09/28/2026 04:00 PM Eastern

Extended Trading

$20.15 +0.09 (+0.45%)

As of 04:31 AM Eastern

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. The company also offers marketing solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest HCAT, CTEV, NRC, and EVH Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest HCAT, CTEV, NRC, and EVH Earnings

Compare Dividends

Latest HCAT, CTEV, NRC, and EVH Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

HCAT, CTEV, NRC, and EVH Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

HCAT, CTEV, NRC, and EVH Company Descriptions

Claritev NYSE:CTEV

Evolent Health NYSE:EVH

Health Catalyst NASDAQ:HCAT

National Research NASDAQ:NRC

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools